The device itself, and we can only give ranges o per fda regulations, it might be kind ofa 200 dollars ange. And then the device can run up to about three thousand to five thousand tests in its lifetime. How much each test costs is something we're still trying to determine. We want to bring down the price as much as possible to increase access but obviously there are costs of manufacturing involved.
Dr. Michael Blaivas, Chief Medical Officer at Anavasi Diagnostics, discusses the importance of Covid tests for the omicron variant. Bloomberg Businessweek Markets and Finance Editor Pat Regnier and Bloomberg News Markets Reporter Justina Lee share the details of Justina's Businessweek Magazine story Wall Street Wants to Sell a Special Index, Just for You. Bloomberg New Economy Editorial Director Andy Browne explains how a tennis star may really hurt China. And we Drive to the Close with Brad McMillan, CIO at Commonwealth Financial Network.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.